Greater Cannabis Company (GCAN) EBITDA (2017 - 2026)
Greater Cannabis Company's (GCAN) quarterly EBITDA came in at -$33376.0 in Q1 2026, up 23.34% year-on-year from -$27060.8 in Q1 2025, and up 37.97% quarter-over-quarter from -$53806.0 in Q4 2025.
Greater Cannabis Company (GCAN) EBITDA (2017 - 2026) Analysis & Trends
Greater Cannabis Company's EBITDA history runs 10 years deep, the most recent figure standing at -$33376.0 for Q1 2026.
- On a quarterly basis, EBITDA rose 23.34% year-over-year to -$33376.0 in Q1 2026; TTM through Mar 2026 was -$172845.0, a 7.45% decrease from a year earlier, with the FY2025 full-year figure at -$183005.0, down 17.1% from the prior year.
- EBITDA grew to -$33376.0 in Q1 2026 per GCAN's latest filing, from -$53806.0 in the prior quarter.
- Across five years, EBITDA topped out at -$33376.0 in Q1 2026 and bottomed at -$53806.0 in Q4 2025.
- The 5-year median for EBITDA is -$42267.0 (2022), against an average of -$42650.4.
- Across the five-year window, EBITDA surged 64.81% in 2022 and slumped 43.01% in 2025, its largest moves.
- Year by year, EBITDA stood at -$42267.0 in 2022, then fell by 4.16% to -$44027.0 in 2023, then rose by 14.54% to -$37625.0 in 2024, then slumped by 43.01% to -$53806.0 in 2025, then soared by 37.97% to -$33376.0 in 2026.
- Per Business Quant, the three latest GCAN EBITDA figures stand at -$33376.0 (Q1 2026), -$53806.0 (Q4 2025), and -$37412.0 (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 652.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 833.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -2.65 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 325.80 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | -79.70 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 193.40 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 291.00 Mn |
| 10 | Greater Cannabis Company | 292,929.85 | 292,929.85 | - | -33,376.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -33,376.00 |
| Dec 31, 2025 | -53,806.00 |
| Sep 30, 2025 | -37,412.00 |
| Jun 30, 2025 | -48,251.00 |
| Mar 31, 2025 | -43,536.00 |
| Dec 31, 2024 | -37,625.00 |
| Sep 30, 2024 | -40,443.00 |
| Jun 30, 2024 | -39,257.00 |
| Mar 31, 2024 | -38,951.00 |
| Dec 31, 2023 | -44,027.00 |
| Sep 30, 2023 | -50,465.00 |
| Jun 30, 2023 | -41,404.00 |
| Mar 31, 2023 | -39,468.00 |
| Dec 31, 2022 | -42,267.00 |
| Sep 30, 2022 | -49,304.00 |
| Jun 30, 2022 | -43,034.00 |
| Mar 31, 2022 | -42,430.00 |
| Dec 31, 2021 | -120,102.00 |
| Sep 30, 2021 | -74,338.00 |
| Jun 30, 2021 | -62,474.00 |